id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-273553-xp4nfnq3	Ramatillah, D. L.	TREATMENT PROFILES AND CLINICAL OUTCOMES OF COVID-19 PATIENTS AT PRIVATE HOSPITAL IN JAKARTA	2020-10-16		.txt	text/plain	3967	217	54	Conclusion: The most effective antiviral agent in this study based on treatment duration was the combination of Oseltamivir + Hydroxychloroquine.The higher the patient's average treatment duration, the lower the average survival rate for COVID-19 patients. Samples used in this study were patients with confirmed COVID-19 who were undergoing treatment and receiving antiviral agent therapy. Patients receiving the combination Oseltamivir + Chloroquine therapy had an average survival rate of about 17% after about 23 days of treatment. Meanwhile, patients who received combination therapy Favipiravir + Oseltamivir + Chloroquine had an average survival rate of about 10% after undergoing treatment for about 39 days. Based on the Chi-Square test, it was found that there was a significant relationship between COVID-19 antiviral agent therapy and the clinical outcome of COVID-19 patients (p = 0.025). Based on the Chi-Square test, there was no significant effect between gender (p = 0.174) and age (p = 0.065) on the clinical outcome of COVID-19 patients.	./cache/cord-273553-xp4nfnq3.txt	./txt/cord-273553-xp4nfnq3.txt